7hc is an Italian innovative startup. The company aim is to develop a computational platform service to support the rational design, screening, and optimization of a specific binder for a protein target, to become a benchmark for the design, development and optimization of novel drugs.
The idea was born, in fact, in order to provide effective support to the pharmaceutical industry and, more generally, to companies operating in the economic sector which integrates the research, design and development of drugs for human or veterinary medicine. 7hc fits into this context with a clear goal: to use information technologies and algorithms at the frontier of scientific research with the idea of putting them at the service of the pharmaceutical industry in order to improve the design process and optimization of drugs.
The necessity of resources optimization is evident when considering that, on average, 12-14 years and more than 1 billion euro are required to bring to market a drug from the time of its discovery. Currently the process of development of a molecule is characterized by a very high number of failures, due in large part to inadequate pharmacokinetics, lack of efficacy, toxicity, side effects in humans and various commercial factors. The recent scientific literature demonstrated that an accurate estimate, fast, reproducible and low cost of the pharmacokinetics of a candidate molecule significantly reduces cost and time required to develop a drug.